Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122594) titled 'Remimazolam or Ciprofol Combined with Alfentanil for Painless Oocyte Retrieval: A Case-Control Study' on April 15.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Shanghai First Maternity and Infant Hospital
Condition:
Infertility
Intervention:
Remimazolam group (R group) :None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-05
Target Sample Size: Remimazolam group (R group) :118;Ciprofol group (C group) :118;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=305926
Published by HT ...